# OnCo record rgd-integrin-radioligands (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/rgd-integrin-radioligands/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "rgd-integrin-radioligands" ;
  schema:name "RGD integrin radioligands"@en ;
  schema:alternateName "RGD peptides"@en, "radiolabelled RGD peptides"@en, "integrin alphavbeta3 PET"@en, "Galacto-RGD"@en, "RGD PET"@en ;
  schema:description "Small radioactive peptides that stick to a protein called integrin alpha-v beta-3, found on new blood vessels growing into tumours and on some cancer cells. On a PET scan they show where a tumour is building blood vessels."@en ;
  schema:url <https://onco.cc/technologies/rgd-integrin-radioligands/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://doi.org/10.1371/journal.pmed.0020070>, <https://doi.org/10.1158/1078-0432.CCR-07-0528>, <https://doi.org/10.1215/15228517-2009-024> ;
  onco:status "emerging" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/> ;
  onco:sections <https://onco.cc/fronts/radiopharma/>, <https://onco.cc/fronts/imaging/> ;
  onco:technologies <https://onco.cc/technologies/radioligand-therapy/>, <https://onco.cc/technologies/antiangiogenic/>, <https://onco.cc/technologies/fapi-pet/> ;
  onco:targets <https://onco.cc/targets/itgav/>, <https://onco.cc/targets/itgb3/> ;
  onco:institutions <https://onco.cc/institutions/tum-munich/> ;
  onco:terms <https://onco.cc/terms/angiogenesis/> .